American Express: Buy the Patient Recovery — A Conservative Long as Spending Normalizes
American Express (AXP) looks like a recovery-in-progress rather than a breakout story. The business retains strong fundamentals - a closed-loop network, high ROE (32.6%), and healthy free cash flow ($14.3B) - while the stock trades at a reasonable ~19x 2026 EPS. This trade idea frames a patient long: enter around current levels, limit downside with…